340257-60-5 Usage
Uses
Used in Pharmaceutical Industry:
TRYPTAMINE-ALPHA,ALPHA,BETA,BETA-D4 HCL is used as a key intermediate for the synthesis of various biologically active compounds, such as neurotransmitters and psychedelics, for research and therapeutic purposes. Its presence in plants makes it a valuable resource for the development of novel drugs and treatments.
Used in Research and Development:
TRYPTAMINE-ALPHA,ALPHA,BETA,BETA-D4 HCL is used as a research compound to study the structure, function, and interactions of tryptamine and its derivatives. This helps scientists better understand the mechanisms of action of these compounds and their potential applications in medicine and pharmacology.
Used in Plant Biology:
As TRYPTAMINE-ALPHA,ALPHA,BETA,BETA-D4 HCL occurs naturally in plants, it can be used to study the biosynthesis and metabolic pathways of tryptamine and its related compounds in plants. This knowledge can be applied to improve plant breeding and cultivation techniques, as well as to develop new plant-derived pharmaceuticals and nutraceuticals.
Used in Chemical Synthesis:
TRYPTAMINE-ALPHA,ALPHA,BETA,BETA-D4 HCL can be used as a starting material or a building block in the chemical synthesis of various tryptamine-based compounds. This allows for the development of new drugs, pharmaceuticals, and other bioactive molecules with potential applications in medicine, agriculture, and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 340257-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,0,2,5 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 340257-60:
(8*3)+(7*4)+(6*0)+(5*2)+(4*5)+(3*7)+(2*6)+(1*0)=115
115 % 10 = 5
So 340257-60-5 is a valid CAS Registry Number.
340257-60-5Relevant articles and documents
Alpha, beta-deuterated amine compound, deuterated drug and preparation method thereof
-
Paragraph 0024-0025, (2021/03/03)
The invention relates to an alpha, beta-deuterated amine compound, a deuterated drug and a reduction deuteration method of a nitrile organic matter for synthesizing the alpha, beta-deuterated amine compound. The method is characterized by comprising the f
Tandem H/D Exchange-SET Reductive Deuteration Strategy for the Synthesis of α,β-Deuterated Amines Using D2O
Luo, Shihui,Weng, Chaoqun,Qin, Zixuan,Li, Ke,Zhao, Tianxiao,Ding, Yuxuan,Ling, Chen,Ma, Yuan,An, Jie
, p. 11862 - 11870 (2021/09/13)
α,β-Deuterated amines are crucial for the development of deuterated drugs. We intend to introduce the novel tandem H/D exchange-single electron transfer (SET) reductive deuteration strategy with high pot- and reagent-economy by the synthesis of α,β-deuterated amine using nitrile as the precursor. The H/D exchange of the -CH2CN group was achieved by D2O/Et3N, which were also the required reagents in the tandem SmI2-mediated SET reductive deuteration of the α-deuterated nitrile. The potential application of this method was further showcased by the synthesis of bevantolol-d4.